Search

Your search keyword '"Mazzola G"' showing total 394 results

Search Constraints

Start Over You searched for: Author "Mazzola G" Remove constraint Author: "Mazzola G" Language english Remove constraint Language: english
394 results on '"Mazzola G"'

Search Results

1. Behavioral and clinical characteristics of people receiving medical care for HIV infection in an outpatient facility in Sicily, Italy

4. Multidirectional Scratch Detection and Restoration in Digitized Old Images

6. Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents

10. Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct‐acting antivirals? A prospective multicentre study

12. Burden of Disease in PWH Harboring a Multidrug-Resistant Virus: Data from the PRESTIGIO Registry

14. Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9)

17. INFLUENCE OF HIV INFECTION AND ANTIRETROVIRAL THERAPY ON AORTIC STIFFNESS

21. Geminal embedding scheme for optimal atomic basis set construction in correlated calculations.

31. Dynamic Perception Map of Urban Area for Social Surveillance

32. Application of guidelines for the management of nonalcoholic fatty liver disease in three prospective cohorts of HIV‐monoinfected patients.

33. Fluctuations in the ensemble of reaction pathways.

34. Liver disease severity and low bone mineral density in HIV mono-infected and HIV/HCV co-infected patients

35. Hegel’s Conceptual Group Action on Creative Dynamics in Music

37. Weak D and partial D: our experience in daily activity

41. OC.07.1 DIRECT ACTING ANTIVIRALS AFTER SUCCESSFUL TREATMENT OF EARLY HEPATOCELLULAR CARCINOMA IMPROVE SURVIVAL AND REDUCE HEPATIC DECOMPENSATION IN HCV-CIRRHOTIC PATIENTS

42. PC.01.10 LIVER AND CARDIOVASCULAR MORTALITY AFTER DAAS: DATA FROM THE RESIST-HCV COHORT

43. Direct acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients

46. Rituximab for managing relapsing or refractory patients with idiopathic thrombotic thrombocytopenic purpura – haemolytic uraemic syndrome

47. Relapsing or refractory idiopathic thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the role of rituximab

48. Prevalence and risk factors for advanced liver fibrosis in HIV/HCV-coinfected individuals

49. A new cosmetic treatment for cellulite: A pilot multicentric study

Catalog

Books, media, physical & digital resources